Login to Your Account



Oncology-Focused Igeneon Raises EUR26.7M, Ponders IPO

By Douglas Merrill


Wednesday, March 3, 2004
Igeneon AG raised €26.7 million in a third-round venture financing and landed Burrill & Co., of San Francisco, as a co-lead investor. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription